Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial
Boehringer Ingelheim
Julio Rosenstock; Vlado Perkovic; Odd Erik Johansen; Mark E Cooper; Steven E Kahn; Nikolaus Marx; John H Alexander; Michael Pencina; Robert D Toto; Christoph Wanner; Bernard Zinman; Hans Juergen Woerle; David Baanstra; Egon Pfarr; Sven Schnaidt; Thomas Meinicke; Jyothis T George; Maximilian von Eynatten; Darren K McGuire